Warning on patient data from medicines reviews

  • 16 January 2006

Pharmacists are being warned not to e-mail medicines use reviews to GPs until concerns over confidentiality have been addressed.

The Pharmaceutical Services Negotiating Committee says there has been an “exponential increase” in the number of medicines use reviews (MURs) currently being carried out by pharmacists and that many GPs have asked to receive the MUR forms electronically.

However very few of England’s 10,500 pharmacists are so far connected to N3 and the NHS email system, Contact, so use of e-mail could put the security of confidential patient information at risk.

The PSNC has asked Connecting for Health to provide advice to the profession on whether it is acceptable to e-mail the MUR forms from an e-mail account outside of Contact. In the meantime it is advising pharmacists not to e-mail MURs.

The committee says a short term alternative may be for electronic copies of MUR forms to be saved to a CD-ROM or other memory device such as a USB memory stick and then be taken to the GP surgery.

MURs were introduced as an advanced service under the new pharmacy contract in April 2005. Pharmacists receive a payment for reviewing medication with patients and then sending a record of the review and any recommended changes to the patient’s GP.

The problems over electronic MURs and IT links with GP surgeries has also been taken up by the All Party Pharmacy Group of MPs. The group is to raise the issue at a meeting with Jane Kennedy, the health minister responsible for pharmacy, next week.

Connecting for Health told EHI Primary Care in December that MURs are not part of CfH’s remit.

Link

PSNC advice

 

Subscribe To Our Newsletters

Subscribe to our newsletter

Subscribe To Our Newsletter

Related News

Tees, Esk and Wear Valleys signs contract to deploy Access EPR

Tees, Esk and Wear Valleys signs contract to deploy Access EPR

Tees, Esk and Wear Valleys NHS Foundation Trust has signed a contract with The Access Group to implement its Rio Evo EPR.
Government considers use of break clause in Palantir NHS contract

Government considers use of break clause in Palantir NHS contract

Government figures are reported to be considering triggering a break clause in Palantir’s NHS federated data platform (FDP) contract.
UK Biobank to get access to GP patient data for research

UK Biobank to get access to GP patient data for research

The government will grant approval for UK Biobank researchers to access coded GP patient data for research purposes.